AKRX News and Press, Akorn Inc. From 05/20/19

LAKE FOREST, Ill., May 20, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that management will present at the 2019 RBC Capital Markets Healthcare Conference on Wednesday, May 22, 2019 at 2:05 p.m. EDT in New York...

If you have followed me on SeekingAlpha for the last few years, then you are well aware of the drama surrounding Akorn Pharmaceuticals ( AKRX ). Although the company has had a checkered past, I believe the company presents an intriguing opportunity for investors with a high level of risk tol...

Teva Pharmaceutical Industries (NYSE: TEVA ) slumps  8%  premarket on light volume as investors react to its role in alleged price fixing by generic drug firms. Last night, the investigative journalism show 60 Minutes aired a piece on the issue that named the company as one of th...

Gainers:  Attis Industries (NASDAQ: ATIS ) +49% . MACOM Technology Solutions Holdings (NASDAQ: MTSI ) +28% . Akorn (NASDAQ: AKRX ) +28% . Chanticleer Holdings (NASDAQ: BURG ) +26% . Corindus Vascular Robotics (NYSEMKT: CVRS ) +21% . Avalara (NYSE: AVLR ) +20% . Conformis (NASDAQ...

Akorn, Inc. (AKRX) Q1 2019 Earnings Conference Call May 07, 2019 10:00 AM ET Company Participants Jennifer Bowles - Senior Vice President and Corporate Strategy & Investor Relations Douglas Boothe - President & Chief Executive Officer Duane Portwood - Chief Financial Offi...

Gainers:  Bridgeline Digital (NASDAQ: BLIN ) +30% . Cohu (NASDAQ: COHU ) +27% . ATA (NASDAQ: ATAI ) +25% . ARCA biopharma (NASDAQ: ABIO ) +24% . SolarEdge Technologies (NASDAQ: SEDG ) +23% . Summit Wireless Technologies (NASDAQ: WISA ) +22% . Itron (NASDAQ: ITRI ) +21% . Sunwor...

Bridgeline Digital (NASDAQ: BLIN ) +37%  on announcing OrchestraCMS multi-year license renewal with global biopharmaceutical company. More news on: Bridgeline Digital, Inc., Akorn, Inc., Akoustis Technologies, Inc., Stocks on the move, Read more ...

Akorn ( AKRX ) Q1 results : Revenues: $165.9M (-9.9%). More news on: Akorn, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...

Akorn (NASDAQ: AKRX ): Q1 Non-GAAP EPS of -$0.10 beats by $0.07 ; GAAP EPS of -$0.65. More news on: Akorn, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...

-Operational improvements drive sequential growth- -Full year outlook anticipates further sequential growth throughout the year- LAKE FOREST, Ill., May 07, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced its&#...